What Has Driven the Growth of the GMP Cell Therapy Consumables Market in Recent Years?
The gmp cell therapy consumables market has seen considerable growth due to a variety of factors.
•The market size for consumables in GMP cell therapy has witnessed a skyrocketing increase in recent years. The market value, projected to rise from $17.85 billion in 2024 to $22.87 billion in 2025, is expected to record a compound annual growth rate (CAGR) of 28.1%.
Factors such as expansion in regenerative medicine investments, cell therapy research progression, approvals and clinical trials, augmenting chronic diseases, and growing consciousness about personalized medicine have contributed to this significant growth during the historical period.
What is the Market Size Forecast for the GMP Cell Therapy Consumables Market?
The gmp cell therapy consumables market is expected to maintain its strong growth trajectory in upcoming years.
• An exponential growth has been projected for the GMP cell therapy consumables market in the upcoming years. By 2029, a surge to $59 billion at a compound annual growth rate (CAGR) of 26.7% is anticipated.
This significant growth within the forecasted period can be attributed to factors such as the broadening of cell therapy applications, a worldwide increase in cell therapy trials, support from regulatory bodies for cell therapies, the development of advanced cell therapy platforms, and the globalization of cell therapy manufacturing. Major trends anticipated during this period include investment in manufacturing infrastructure, technological advancements in cell processing, collaborations and partnerships, the integration of digitalization and data, and strategic alliances and mergers.
What Factors Are Driving Growth In The GMP Cell Therapy Consumables Market?
Anticipations of a boost in drug discovery are set to drive the expansion of the GMP cell therapy consumables market. The term "drug discovery" denotes the creation of potential new medicinal substances through the integration of computational, experimental, translational, and clinical models. Innovations in bioinformatics, genetics, molecular biology, and high-throughput screening have given drug discovery a new life. This allows scientists to gain deeper knowledge of disease mechanisms, discover possible drug targets, and proficiently screen extensive libraries of compounds for potential drug candidates. As a result, increased drug discovery is attributing to the rise of the GMP cell therapy consumables market. For example, the US's Food and Drug Administration, a federal agency that is part of the Department of Health and Human services, reported in January 2023 that 37 new drugs and therapeutic biological products received approval from FDA’s Centre for Drug Evaluation and Research (CDER) in the US in 2022 for different indications. Hence, the growth in drug discovery is fuelling the growth of the GMP cell therapy consumables market.
What Are The Main Segments Of The Global GMP Cell Therapy Consumables Market?
The GMP cell therapy consumables market covered in this report is segmented –
1) By Product: Kits, Reagents Or Molecular Biology reagents, Growth Factors Or Cytokines And Interleukins, Other Products
2) By Cell Therapy: NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, Other cell therapies
3) By Process: Cell Collection And Characterization Or Sorting And Separation, Cell Culture And Expansion Or Preparation, Cryopreservation, Cell Processing And Formulation, Cell Isolation And Activation, Cell Distribution Or Handling, Process Monitoring And Control Or Readministration Or Quality Assurance, Other Processes
4) By End-Use: Clinical, Commercial, Research
Subsegments:
1) By Kits: Cell Culture Kits, Cell Isolation Kits, Transfection Kits
2) By Reagents Or Molecular Biology Reagents: Buffers And Solutions, Enzymes, Staining Reagents
3) By Growth Factors Or Cytokines And Interleukins: Hematopoietic Growth Factors, Antibody Cytokines, Immunomodulatory Cytokines
3) By Other Products: Cell Culture Vessels, Bioreactors, Media And Supplements
Pre-Book The GMP Cell Therapy Consumables Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The GMP Cell Therapy Consumables Market?
Leading enterprises in the GMP cell therapy consumables market are making strides to support advanced therapies by creating GMP-compliant CD34+ hematopoietic stem cells (HSCs). These are a particular type of stem cell marked by the CD34 and manufactured under Good Manufacturing Practice (GMP) regulations. For example, in April 2024, the US pharmaceutical organization OrganaBio debuted HematoPAC-HSC-CB-GMP, a readily accessible source of GMP-compliant CD34+ HSCs harvested from fresh human cord blood. Drawing from its vast background in cell segregation and GMP fabrication, OrganaBio can generate large quantities of highly viable CD34+ HSCs within a single day of collection. This initiation is designed to expedite the fruition of new-age therapies, particularly those catering to blood cancers and genetic ailments.
Who Are the Key Players in the GMP Cell Therapy Consumables Market?
Major companies operating in the GMP cell therapy consumables market include:
• Thermo Fisher Scientific Inc.
• Fresenius Kabi AG
• Danaher Corporation
• Merck KGaA
• Asahi Kasei Corporation
• GE HealthCare Technologies Inc.
• Corning Incorporated
• Avantor Inc.
• Lonza Group AG
• Terumo Corporation
• Catalent Inc.
• Sartorius AG
• Bio-Techne Corp
• Repligen Corporation
• Miltenyi Biotec BV & Co KG
• Genscript Biotech Corporation
• Rentschler Biopharma SE
• FUJIFILM Irvine Scientific Inc.
• BioLegend Inc.
• STEMCELL Technologies Inc.
• BioLife Solutions Inc.
• Abzena Ltd.
• Sino Biological Inc.
• ProBioGen AG
• MaxCyte Inc.
• PromoCell GmbH
• PeproTech Inc.
• Cellares Corp.
• Wilson Wolf Corporation
• Cellexus Ltd.
What Is The Most Dominant Region In The GMP Cell Therapy Consumables Market?
North America was the largest region in the GMP cell therapy consumables market in 2024. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the GMP cell therapy consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
